Wesana Health (WSNAF) Corporate Presentation from NobleCon18News and Market Data on Wesana HealthNobleCon 18 Complete Rebroadcast
|
Access to Exclusive Content. FREE for Registered Users Only.
Join the Channelchek Investor Community to access equity research, video content, events, and much more. All at no cost.
‌


Welcome to the Channelchek Investor Community
We’ve updated the entire site to bring you faster navigation and increased content at every level. Channelchek is now North America’s leading platform for access to regulated and independent company sponsored equity research.
Don't have an account? Join
Forgot passwordBy clicking “Log In” you agree to Channelchek.com Terms of Use and acknowledge that Channelchek.com Privacy Policy applies to you.
Related News
‌


1/22/2026
Aerospace and Defense
Release – V2X and Bell Advance to Phase II of the US Army’s Flight School Next Competition
V2X Inc. (NYSE: VVX)Â is proud to announce its advancement to Phase II of the US Army’s Flight School Next (FSN) competition, as part of the Bell Textron Inc. led team...
3 min read
‌


1/22/2026
Healthcare
Release – SelectQuote to Release Fiscal Second Quarter 2026 Earnings on February 5
SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly growing Healthcare Services platform, today announced it will release its fiscal second quarter 2026...
3 min read
‌


1/22/2026
Industrials
Release – The GEO Group Announces Expansion of Revolving Credit Facility by $100 Million
The GEO Group, Inc. (NYSE: GEO) (“GEO” or the “Company”) announced today the closing of an amendment to the Company’s Amended Credit Agreement to increase GEO’s Revolving Credit Facility commitments from $450 million to $550...
3 min read
‌


1/22/2026
Health
Release – Greenwich LifeSciences Announces FDA Approves Use of Commercially Manufactured GP2 in FLAMINGO-01
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences,...
8 min read
Inbox Intel from Channelchek.
Informed investors make more money. And it’s all about timing. Get it when it happens.